| EPB183 | Week 96 weight and lipid changes from baseline among participants receiving cabotegravir and rilpivirine long-acting or comparator therapy in the ATLAS-2M and FLAIR studies | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPB184 | Injection site reaction experience in clinical studies of people using lenacapavir for HIV treatment | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPB185 | Preference for long acting injectable (LAI) antiretrovirals for HIV treatment or PrEP in Argentina | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPB186 | Early implementation and clinical outcomes of long-acting injectable cabotegravir and rilpivirine in a safety-net HIV clinic | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPLBB05 | Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir + rilpivirine long-acting into European clinical settings | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| PESUB24 | A study evaluating the safety, tolerability, and pharmacokinetics of a high-concentration (CAB 400mg/ml) cabotegravir long-acting injectable formulation following subcutaneous and intramuscular administration in healthy adult participants | Poster exhibition | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPE274 | Improving treatment outcomes among adolescents and young people living with HIV in the coastal region of Kenya through operation triple zero (OTZ) | E-poster | Making health systems work for adolescents |
| OALBE0102 | SEARCH-Youth: a cluster randomized trial of a multilevel health system intervention to improve virologic suppression in adolescents and young adults living with HIV in rural Kenya and Uganda | Oral abstract session with live Q&A | Making health systems work for adolescents |
| EPB085 | HIV status is associated with reduced risk for precancerous lesions | E-poster | Malignancies (AIDS and non-AIDS) |
| EPB086 | Retention in care in pregnant HIV positive Kaposi Sarcoma (KS) patients seen at a tertiary hospital in Harare, Zimbabwe: a case control study | E-poster | Malignancies (AIDS and non-AIDS) |